Mais Jebrail
Mais Jebrail, PhD, is the CTO of Microfluidics at INTEGRA Biosciences and an expert in microfluidics with extensive experience in the biotech industry, ranging from chemistry to clinical applications. He completed his PhD at the University of Toronto and pursued postdoctoral research at Sandia National Labs. At INTEGRA Biosciences, he is driving innovation in microfluidic technologies for life sciences. With a strong background in technology development and commercialization, Dr. Jebrail has contributed to multiple patents and has published many peer-reviewed papers in the areas of microfluidic device design, diagnostic applications, and next-generation sequencing. He continues to push the boundaries of microfluidics in biotechnology.
INTEGRA Bioscience
Pioneers in Pharma Manufacturing: Using Synthetic Biology to Build New, Innovative Complex Chemical Structures
-
As demand for genetic medicines grows, traditional manufacturing methods are reaching their limits. Leaders in pharma and synbio explore what’s driving innovation in cell and gene therapy (CGT), RNA/DNA therapeutics, and other complex manufacturing spaces, with insights from plasmid DNA production, vaccine manufacturing, and the broader chemicals sector.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
